William Joseph Barbaresi

Publications

1. ADHD Prescription Patterns: Paying Attention to Trends. Pediatrics. 2025 Feb 01; 155(2). View Abstract
2. Characteristics of Young Children Associated with Diagnostic Utility of the Autism Diagnostic Observation Schedule: A DBPNet Study. J Dev Behav Pediatr. 2024 Nov 26. View Abstract
3. The Impact of Face Mask Use on Research Evaluations of 5-7 Year-Old Children With Autism Spectrum Disorder. J Autism Dev Disord. 2024 Nov 23. View Abstract
4. Developmental and Psychiatric Conditions Among 5-7 Year Old Children with Non-persistent and Persistent Autism. J Autism Dev Disord. 2024 Nov 09. View Abstract
5. Diverse clinical presentation of SPTBN1 variants: Complex versus primary attention-deficit/hyperactivity disorder. Am J Med Genet A. 2025 Jan; 197(1):e63851. View Abstract
6. Considerations in Early Autism Diagnosis-Reply. JAMA Pediatr. 2024 Apr 01; 178(4):417-418. View Abstract
7. Engagement of adolescents with ADHD in a narrative-centered game-based behavior change environment to reduce alcohol use. Front Educ (Lausanne). 2023; 8. View Abstract
8. Rare De Novo and Inherited Genes in Familial and Nonfamilial Pediatric Attention-Deficit/Hyperactivity Disorder. JAMA Pediatr. 2024 Jan 01; 178(1):81-84. View Abstract
9. Assessment and Documentation of Language Disorders in Young Children: Challenges and Opportunities. J Dev Behav Pediatr. 2024 01 01; 45(1):e4-e7. View Abstract
10. Persistence of Autism Spectrum Disorder From Early Childhood Through School Age. JAMA Pediatr. 2023 11 01; 177(11):1197-1205. View Abstract
11. Co-occurring conditions in Down syndrome: Findings from a clinical database. Am J Med Genet C Semin Med Genet. 2023 12; 193(4):e32072. View Abstract
12. Receipt of Behavioral Therapy in Preschool-Age Children with ADHD and Coexisting Conditions: A DBPNet Study. J Dev Behav Pediatr. 2023 12 01; 44(9):e651-e656. View Abstract
13. Do Externalizing and Internalizing Symptoms Moderate Medication Response in Preschool Attention-Deficit/Hyperactivity Disorder? A DBPNet Study. J Dev Behav Pediatr. 2023 09 01; 44(7):e447-e454. View Abstract
14. Adverse Effects of a-2 Adrenergic Agonists and Stimulants in Preschool-age Attention-deficit/Hyperactivity Disorder: A Developmental-Behavioral Pediatrics Research Network Study. J Pediatr. 2023 06; 257:113325. View Abstract
15. Male and Female Toddlers with DSM-5 Autism Spectrum Disorder have Similar Developmental Profiles and Core Autism Symptoms. J Autism Dev Disord. 2024 Mar; 54(3):955-962. View Abstract
16. Clinician Diagnostic Certainty and the Role of the Autism Diagnostic Observation Schedule in Autism Spectrum Disorder Diagnosis in Young Children. JAMA Pediatr. 2022 12 01; 176(12):1233-1241. View Abstract
17. Development and implementation of a longitudinal clinical database for down syndrome in a large pediatric specialty clinic: Methodology and feasibility. J Intellect Disabil. 2024 Mar; 28(1):196-215. View Abstract
18. Association of Coexisting Conditions, Attention-Deficit/Hyperactivity Disorder Medication Choice, and Likelihood of Improvement in Preschool-Age Children: A Developmental Behavioral Pediatrics Research Network Study. J Child Adolesc Psychopharmacol. 2022 08; 32(6):328-336. View Abstract
19. Description of Clinician-Diagnosed Regression at Time of Autism Spectrum Disorder Diagnosis in Toddlers. J Dev Behav Pediatr. 2022 09 01; 43(7):377-385. View Abstract
20. Correction to: Identifying Subgroups of Toddlers with DSM-5 Autism Spectrum Disorder Based on Core Symptoms. J Autism Dev Disord. 2021 Dec; 51(12):4486-4487. View Abstract
21. Language Screening in 3-Year-Olds: Development and Validation of a Feasible and Effective Instrument for Pediatric Primary Care. Front Pediatr. 2021; 9:752141. View Abstract
22. Preschool Attention-Deficit/Hyperactivity Disorder and Telephone Medication Management at Developmental-Behavioral Pediatric Network Sites. J Dev Behav Pediatr. 2021 08 01; 42(6):481-484. View Abstract
23. a2-Adrenergic Agonists or Stimulants for Preschool-Age Children With Attention-Deficit/Hyperactivity Disorder. JAMA. 2021 05 25; 325(20):2067-2075. View Abstract
24. Identifying Subgroups of Toddlers with DSM-5 Autism Spectrum Disorder Based on Core Symptoms. J Autism Dev Disord. 2021 Dec; 51(12):4471-4485. View Abstract
25. Recalled Experiences of Bullying and Victimization in a Longitudinal, Population-Based Birth Cohort: The Influence of ADHD and Co-Occurring Psychiatric Disorder. J Atten Disord. 2022 01; 26(1):15-24. View Abstract
26. Children With ADHD Are at Risk for a Broad Array of Adverse Adult Outcomes That Cross Functional Domains: Results From a Population-Based Birth Cohort Study. J Atten Disord. 2022 01; 26(1):3-14. View Abstract
27. Pathogenic Yield of Genetic Testing in Autism Spectrum Disorder. Pediatrics. 2020 10; 146(4). View Abstract
28. Is it feasible to assess self-reported quality of life in individuals who are deaf and have intellectual disabilities? Soc Psychiatry Psychiatr Epidemiol. 2021 Oct; 56(10):1881-1890. View Abstract
29. The SDBP Complex ADHD Clinical Practice Guideline: It's About Time. J Dev Behav Pediatr. 2020 Feb/Mar; 41 Suppl 2S:S33-S34. View Abstract
30. Supplementary Evidence Tables for Treatment of Complex Attention-Deficit/Hyperactivity Disorder. J Dev Behav Pediatr. 2020 Feb/Mar; 41 Suppl 2S:s111-s148. View Abstract
31. Developing the Evidence-Grading Tools and Process for the Complex Attention-Deficit/Hyperactivity Disorder Guideline. J Dev Behav Pediatr. 2020 Feb/Mar; 41 Suppl 2S:S105-S110. View Abstract
32. Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder. J Dev Behav Pediatr. 2020 Feb/Mar; 41 Suppl 2S:S35-S57. View Abstract
33. The Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder: Process of Care Algorithms. J Dev Behav Pediatr. 2020 Feb/Mar; 41 Suppl 2S:S58-S74. View Abstract
34. Feasibility and Outcomes of the Early Start Denver Model Implemented with Low Intensity in a Community Setting in Austria. J Dev Behav Pediatr. 2019 06; 40(5):354-363. View Abstract
35. High-Functioning Autism, Severe Anxiety, and Bullying in a 26 Year Old. J Dev Behav Pediatr. 2019 05; 40(4):312-314. View Abstract
36. Common Use of Stimulants and Alpha-2 Agonists to Treat Preschool Attention-Deficit Hyperactivity Disorder: A DBPNet Study. J Dev Behav Pediatr. 2018 09; 39(7):531-537. View Abstract
37. Using ADHD Medications to Treat Coexisting ADHD and Reading Disorders: A Systematic Review. Clin Pharmacol Ther. 2018 10; 104(4):619-637. View Abstract
38. Population Health in Pediatric Speech and Language Disorders: Available Data Sources and a Research Agenda for the Field. J Speech Lang Hear Res. 2018 05 17; 61(5):1279-1291. View Abstract
39. Topical Review: Transitional Services for Teens and Young Adults With Attention-Deficit Hyperactivity Disorder: A Process Map and Proposed Model to Overcoming Barriers to Care. J Pediatr Psychol. 2017 11 01; 42(10):1108-1113. View Abstract
40. Psychiatric Comorbidities Modify the Association Between Childhood ADHD and Risk for Suicidality: A Population-Based Longitudinal Study. J Atten Disord. 2019 Jun; 23(8):777-786. View Abstract
41. Academic Achievement in Adults with a History of Childhood Attention-Deficit/Hyperactivity Disorder: A Population-Based Prospective Study. J Dev Behav Pediatr. 2017 01; 38(1):1-11. View Abstract
42. Adults With Persistent ADHD: Gender and Psychiatric Comorbidities-A Population-Based Longitudinal Study. J Atten Disord. 2018 04; 22(6):535-546. View Abstract
43. Management of Attention-Deficit/Hyperactivity Disorder by Developmental-Behavioral Pediatricians: A DBPNet Study. J Dev Behav Pediatr. 2016 09; 37(7):541-7. View Abstract
44. Electronic Health Record Based Algorithm to Identify Patients with Autism Spectrum Disorder. PLoS One. 2016; 11(7):e0159621. View Abstract
45. The Meaning of "Regression" in Children with Autism Spectrum Disorder: Why Does It Matter? J Dev Behav Pediatr. 2016 Jul-Aug; 37(6):506-7. View Abstract
46. Mediating and Moderating Role of Depression, Conduct Disorder or Attention-Deficit/Hyperactivity Disorder in Developing Adolescent Substance Use Disorders: A Population-Based Study. PLoS One. 2016; 11(6):e0157488. View Abstract
47. Improving Care for Children With ADHD: The Information is Just a Rating Scale Away. Pediatrics. 2016 Mar; 137(3):e20154450. View Abstract
48. Childhood Attention-Deficit/Hyperactivity Disorder, Sex, and Obesity: A Longitudinal Population-Based Study. Mayo Clin Proc. 2016 Mar; 91(3):352-61. View Abstract
49. Comparing Methods to Determine Persistence of Childhood ADHD Into Adulthood: A Prospective, Population-Based Study. J Atten Disord. 2018 04; 22(6):571-580. View Abstract
50. Comparing Diagnostic Outcomes of Autism Spectrum Disorder Using DSM-IV-TR and DSM-5 Criteria. J Autism Dev Disord. 2015 May; 45(5):1437-50. View Abstract
51. "Complex" attention-deficit hyperactivity disorder, more norm than exception? Diagnoses and comorbidities in a developmental clinic. J Dev Behav Pediatr. 2014 Nov-Dec; 35(9):591-7. View Abstract
52. Update on long-term stimulant medication treatment of attention-deficit hyperactivity disorder. J Dev Behav Pediatr. 2014 Sep; 35(7):446-7. View Abstract
53. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study. J Dev Behav Pediatr. 2014 Sep; 35(7):448-57. View Abstract
54. ADHD, stimulant treatment, and growth: a longitudinal study. Pediatrics. 2014 Oct; 134(4):e935-44. View Abstract
55. Childhood ADHD and risk for substance dependence in adulthood: a longitudinal, population-based study. PLoS One. 2014; 9(8):e105640. View Abstract
56. Dietary docosahexaenoic acid supplementation in children with autism. J Pediatr Gastroenterol Nutr. 2014 Jun; 58(6):715-22. View Abstract
57. ADHD and learning disabilities in former late preterm infants: a population-based birth cohort. Pediatrics. 2013 Sep; 132(3):e630-6. View Abstract
58. Disparity of care for children with parent-reported autism spectrum disorders. Acad Pediatr. 2013 Jul-Aug; 13(4):334-9. View Abstract
59. Mortality, ADHD, and psychosocial adversity in adults with childhood ADHD: a prospective study. Pediatrics. 2013 Apr; 131(4):637-44. View Abstract
60. Incidence of enuresis and encopresis among children with attention-deficit/hyperactivity disorder in a population-based birth cohort. Acad Pediatr. 2013 Jul-Aug; 13(4):322-7. View Abstract
61. Special education and later academic achievement. J Dev Behav Pediatr. 2013 Feb; 34(2):111-9. View Abstract
62. Early speech-language impairment and risk for written language disorder: a population-based study. J Dev Behav Pediatr. 2013 Jan; 34(1):38-44. View Abstract
63. Research priorities for developmental-behavioral pediatrics: a DBPNet consensus study. J Dev Behav Pediatr. 2012 Jul; 33(6):509-16. View Abstract
64. Childhood ADHD is strongly associated with a broad range of psychiatric disorders during adolescence: a population-based birth cohort study. J Child Psychol Psychiatry. 2012 Oct; 53(10):1036-43. View Abstract
65. Attention-deficit/hyperactivity disorder after early exposure to procedures requiring general anesthesia. Mayo Clin Proc. 2012 Feb; 87(2):120-9. View Abstract
66. Written-language disorder among children with and without ADHD in a population-based birth cohort. Pediatrics. 2011 Sep; 128(3):e605-12. View Abstract
67. Developmental and behavioral disorders through the life span. Pediatrics. 2011 Aug; 128(2):364-73. View Abstract
68. Evaluation of the ability of neurobiological, neurodevelopmental and socio-economic variables to predict cognitive outcome in premature infants. Child Care Health Dev. 2012 Sep; 38(5):683-9. View Abstract
69. Author reply: attention-deficit hyperactivity disorder and high intelligence quotient. J Dev Behav Pediatr. 2011 Jun; 32(5):438. View Abstract
70. Attention-deficit hyperactivity disorder in children with high intelligence quotient: results from a population-based study. J Dev Behav Pediatr. 2011 Feb-Mar; 32(2):103-9. View Abstract
71. Gender, attention-deficit/hyperactivity disorder, and reading disability in a population-based birth cohort. Pediatrics. 2010 Oct; 126(4):e788-95. View Abstract
72. Epilepsy in children with attention-deficit/hyperactivity disorder. Pediatr Neurol. 2010 May; 42(5):325-30. View Abstract
73. Anesthesia for cesarean delivery and learning disabilities in a population-based birth cohort. Anesthesiology. 2009 Aug; 111(2):302-10. View Abstract
74. Incidence of gastrointestinal symptoms in children with autism: a population-based study. Pediatrics. 2009 Aug; 124(2):680-6. View Abstract
75. The forgotten learning disability: epidemiology of written-language disorder in a population-based birth cohort (1976-1982), Rochester, Minnesota. Pediatrics. 2009 May; 123(5):1306-13. View Abstract
76. Early exposure to anesthesia and learning disabilities in a population-based birth cohort. Anesthesiology. 2009 Apr; 110(4):796-804. View Abstract
77. Developmental outcomes for neonatal dural arteriovenous fistulas. J Neurosurg Pediatr. 2009 Feb; 3(2):105-9. View Abstract
78. Developmental and behavioral pediatrics grown up: a new JDBP review series. J Dev Behav Pediatr. 2008 Dec; 29(6):523. View Abstract
79. The incidence of clinically diagnosed versus research-identified autism in Olmsted County, Minnesota, 1976-1997: results from a retrospective, population-based study. J Autism Dev Disord. 2009 Mar; 39(3):464-70. View Abstract
80. Stimulant medication treatment of target behaviors in children with autism: a population-based study. J Dev Behav Pediatr. 2008 Apr; 29(2):75-81. View Abstract
81. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med. 2007 Sep; 161(9):857-64. View Abstract
82. Long-term school outcomes for children with attention-deficit/hyperactivity disorder: a population-based perspective. J Dev Behav Pediatr. 2007 Aug; 28(4):265-73. View Abstract
83. Modifiers of long-term school outcomes for children with attention-deficit/hyperactivity disorder: does treatment with stimulant medication make a difference? Results from a population-based study. J Dev Behav Pediatr. 2007 Aug; 28(4):274-87. View Abstract
84. Comparison of the validity of direct pediatric developmental evaluation versus developmental screening by parent report. Clin Pediatr (Phila). 2007 Jul; 46(6):523-9. View Abstract
85. Autism: a review of the state of the science for pediatric primary health care clinicians. Arch Pediatr Adolesc Med. 2006 Nov; 160(11):1167-75. View Abstract
86. Developmental dissociation, deviance, and delay: Occurrence of attention-deficit-hyperactivity disorder in individuals with and without borderline-to-mild intellectual disability. Dev Med Child Neurol. 2006 Oct; 48(10):831-5. View Abstract
87. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study. J Dev Behav Pediatr. 2006 Feb; 27(1):1-10. View Abstract
88. Emergency department use and costs for youth with attention-deficit/hyperactivity disorder: associations with stimulant treatment. Ambul Pediatr. 2006 Jan-Feb; 6(1):45-53. View Abstract
89. Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit/hyperactivity disorder: a population-based, birth cohort study. J Child Adolesc Psychopharmacol. 2005 Oct; 15(5):764-76. View Abstract
90. Math learning disorder: incidence in a population-based birth cohort, 1976-82, Rochester, Minn. Ambul Pediatr. 2005 Sep-Oct; 5(5):281-9. View Abstract
91. Case definition in epidemiologic studies of AD/HD. Ann Epidemiol. 2005 Jul; 15(6):430-7. View Abstract
92. 14q32.3 deletion syndrome with autism. Am J Med Genet A. 2005 Feb 15; 133A(1):99-100. View Abstract
93. The incidence of autism in Olmsted County, Minnesota, 1976-1997: results from a population-based study. Arch Pediatr Adolesc Med. 2005 Jan; 159(1):37-44. View Abstract
94. An opportunity for office-based research. J Dev Behav Pediatr. 2004 Oct; 25(5 Suppl):S84-8. View Abstract
95. Early life risk factors for attention-deficit/hyperactivity disorder: a population-based cohort study. Mayo Clin Proc. 2004 Sep; 79(9):1124-31. View Abstract
96. How common is attention-deficit/hyperactivity disorder? Towards resolution of the controversy: results from a population-based study. Acta Paediatr Suppl. 2004 May; 93(445):55-9. View Abstract
97. The yield of the medical evaluation of children with pervasive developmental disorders. J Autism Dev Disord. 2003 Apr; 33(2):187-92. View Abstract
98. Use of psychotropic medications in young, preschool children: primum non nocere. Arch Pediatr Adolesc Med. 2003 Feb; 157(2):121-3. View Abstract
99. How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minn. Arch Pediatr Adolesc Med. 2002 Mar; 156(3):217-24. View Abstract
100. Boy/girl differences in risk for reading disability: potential clues? Am J Epidemiol. 2001 Nov 01; 154(9):787-94. View Abstract
101. Incidence of reading disability in a population-based birth cohort, 1976-1982, Rochester, Minn. Mayo Clin Proc. 2001 Nov; 76(11):1081-92. View Abstract
102. An opportunity for office-based research. J Dev Behav Pediatr. 2001 Feb; 22(1):35-9. View Abstract
103. Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA. 2001 Jan 03; 285(1):60-6. View Abstract
104. Potential influence of migration bias in birth cohort studies. Mayo Clin Proc. 1998 Nov; 73(11):1053-61. View Abstract
105. An ADHD educational intervention for elementary schoolteachers: a pilot study. J Dev Behav Pediatr. 1998 Apr; 19(2):94-100. View Abstract
106. Primary-care approach to the diagnosis and management of attention-deficit hyperactivity disorder. Mayo Clin Proc. 1996 May; 71(5):463-71. View Abstract
Show All Publications Show Fewer Publications